Insulin is a hormone produced by beta cells in the pancreas. After a meal, carbohydrates are broken down into glucose, which enters the bloodstream. Insulin helps the body's cells take up and use glucose, while also signaling the liver to reduce its glucose production.
When this system works properly, blood glucose rises after eating and gradually returns toward its usual range.
In type 2 diabetes, the system becomes less effective. The liver may continue releasing too much glucose, muscle cells may respond less effectively to insulin, and the pancreas may struggle to produce enough insulin to compensate. Over time, blood glucose can remain elevated for prolonged periods.
Two processes are particularly important:
Insulin resistance: The body's tissues do not respond adequately to insulin. The pancreas initially compensates by producing more of the hormone, but this compensation may become insufficient.
Progressive beta-cell dysfunction: The insulin-producing cells of the pancreas gradually lose their ability to meet the body's metabolic demands.
These processes can occur in people with obesity, but they can also occur in people with normal BMI. Body weight is one part of the picture, not a complete measurement of insulin sensitivity or pancreatic function.
It is also important to distinguish type 2 diabetes from other forms of diabetes. Type 1 diabetes, for example, is an autoimmune condition in which the immune system destroys insulin-producing cells. It can develop at any age and in people of every body size. Adult-onset autoimmune diabetes can initially resemble type 2 diabetes, making clinical evaluation especially important when the presentation is unusual.
Therefore, a diagnosis of diabetes in a lean adult should not automatically be assumed to be type 2 without considering the person's symptoms, medical history, laboratory results, and, when indicated, additional testing.
2. Normal BMI Does Not Guarantee Normal Metabolism
BMI is calculated using a person's weight and height. It is widely used in health research because it is simple, inexpensive, and useful for assessing population-level patterns.
However, BMI has important limitations.
It does not directly measure body fat, distinguish muscle from fat, reveal where fat is stored, or assess how effectively the body regulates glucose. Two people with the same BMI may have substantially different body compositions and metabolic profiles.
One may have relatively high muscle mass and little abdominal fat. Another may have less muscle, more body fat, and greater fat accumulation around internal organs. Their weights may look similar on a chart, yet their risks of insulin resistance and metabolic disease may differ.
This helps explain why some people develop type 2 diabetes despite having a BMI conventionally considered healthy.
Researchers sometimes describe this pattern as metabolically unhealthy normal weight. The term generally refers to people whose BMI is within a normal range but who have one or more metabolic risk factors, such as elevated blood glucose, high triglycerides, low HDL cholesterol, increased blood pressure, or evidence of insulin resistance.
The definition is not identical across all studies, and not everyone with one abnormal marker will develop diabetes. Nevertheless, the concept highlights an important limitation of using body size as a substitute for metabolic assessment.
A normal BMI is reassuring in some respects, but it is not a guarantee that every aspect of metabolic health is normal.
Why this matters for younger adults
Type 2 diabetes has traditionally been associated with middle age and older adulthood. However, it can develop in younger adults, particularly when genetic susceptibility, family history, metabolic risk factors, and environmental influences converge.
Younger people may be less likely to receive screening if they appear fit and have no obvious risk factors. They may also dismiss symptoms such as fatigue, thirst, or frequent urination as consequences of stress or a busy schedule.
The result can be delayed diagnosis.
Recognizing that diabetes can occur at normal weight helps healthcare professionals and patients consider appropriate testing based on the whole clinical picture rather than appearance alone.
3. Visceral Fat: Why Fat Distribution Matters
One of the most important differences between body weight and metabolic health is the location of body fat.
Subcutaneous fat lies beneath the skin. Visceral fat is stored deeper in the abdominal cavity, surrounding internal organs. Both are normal components of human physiology, but excessive visceral fat is associated with a higher risk of insulin resistance and several cardiometabolic conditions.
A person does not need to appear obese to have a relatively high proportion of abdominal or visceral fat.
How visceral fat affects glucose regulation
Visceral fat is metabolically active. It releases fatty acids and signaling molecules that can influence the liver, muscles, and other tissues.
When fat storage and energy regulation become impaired, several processes may contribute to insulin resistance:
-
Increased fatty-acid delivery to the liver: This can contribute to fat accumulation in the liver and disrupt the liver's normal response to insulin.
-
Changes in inflammatory signaling: Adipose tissue can release inflammatory mediators that affect insulin sensitivity.
-
Altered fat-storage capacity: When subcutaneous fat cannot safely store excess energy, more fat may accumulate in locations where it interferes with metabolic function.
-
Changes in signaling between organs: Fat tissue, the liver, skeletal muscle, and pancreas communicate through hormones, metabolites, and other biological signals.
These mechanisms are interconnected. Visceral fat is an important risk marker, but it is not the only cause of diabetes, and it does not explain every case in a person of normal weight.
The role of liver fat
The liver plays a central role in maintaining blood glucose levels. Between meals, it releases glucose to supply the body's energy needs. After eating, insulin normally helps restrain this glucose production.
When excess fat accumulates in the liver, the liver may become less responsive to insulin. It can continue releasing glucose even when the body has enough available, contributing to elevated fasting blood sugar.
Fatty liver disease and type 2 diabetes frequently occur together, although the relationship is complex and not every person with fatty liver develops diabetes.
A person can have liver fat despite a normal BMI, particularly when genetic predisposition, abdominal fat distribution, diet, or other metabolic factors are involved.
What about fat in the pancreas?
Researchers have also investigated fat accumulation in and around the pancreas. Some studies suggest that pancreatic fat is associated with impaired insulin secretion and metabolic dysfunction.
However, the relationship is complex. Measuring pancreatic fat does not, by itself, establish why a particular person developed diabetes. Nor does a routine diagnosis of diabetes mean that someone needs a CT scan or other imaging to search for fat deposits.
For most people, appropriate blood tests, medical history, blood pressure measurement, and assessment of established risk factors are more useful first steps than advanced imaging.
The key message is straightforward: body composition and fat distribution can matter even when total body weight appears unremarkable.
4. Genetics and Family History: The Risk We Cannot See
Lifestyle receives considerable attention in discussions of type 2 diabetes, but genetics also plays a substantial role.
Some people inherit biological characteristics that make them more susceptible to insulin resistance, reduced pancreatic beta-cell function, or particular patterns of fat storage. These differences can affect how the body responds to food, physical activity, aging, and changes in body composition.
Family history is therefore an important clue.